US Patent Issued to Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical on Sept. 30 for "Fused pyridine ring derivative, preparation method therefor, and pharmaceutical use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,396, issued on Sept. 30, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang Jiangsu, China) and Shanghai Hengrui Pharmaceutical Co. Ltd. (Shanghai).

"Fused pyridine ring derivative, preparation method therefor, and pharmaceutical use thereof" was invented by Xiaomin Zhang (Shanghai), Weimin Hu (Shanghai), Feng He (Shanghai) and Chaobaihui Ye (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A fused pyridine ring derivative represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative, and a use thereof as a therapeutic agent, particularly, in preparation of drugs for pre...